Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
US6482919B2 · kind B2 · utility
38Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2001 |
| Grant date | Nov 19, 2002 |
| Priority date | — |
| Expiry date | Mar 21, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/705
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides novel soluble CTLA4Ig molecules having modified Ig domains.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.